Scientists say that an experimental monoclonal antibody drug called mAb43 appears to prevent and reverse the onset of clinical type 1 diabetes in mice, and in some cases, to lengthen the animals‘ lifespan.
Quelle: ScienceDaily | Immune System
Titelbild/Grafik: ScienceDaily News
Kommentare und Fragen
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Weiteres von ScienceDaily | Allergy
- Immune complex shaves stem cells to protect against cancer
- 'Ding-dong:' A study finds specific neurons with an immune doorbell
- Multi-target approach counters tumor growth in several cancers
- Sophisticated early warning system: How bacteria respond to threats
- Protein level predicts immunotherapy response in bowel cancer
- Ultrasound-directed microbubbles could boost immune response against tumors
- Scientists develop tiny anticancer weapon
- 'Perfect storm' of mutations drives infection-triggered autoimmune disease
- Three drug cocktail shows potential to boost CAR-T cancer therapy
- Route of entry for Semliki Forest virus into the brain revealed
